Comparative Transcriptional Network Modeling of Three PPAR-α/γ Co-Agonists Reveals Distinct Metabolic Gene Signatures in Primary Human Hepatocytes
Aims: To compare the molecular and biologic signatures of a balanced dual peroxisome proliferator-activated receptor (PPAR)-α/γ agonist, aleglitazar, with tesaglitazar (a dual PPAR-α/γ agonist) or a combination of pioglitazone (Pio; PPAR-γ agonist) and fenofibrate (Feno; PPAR-α agonist) in human...
Main Authors: | Deehan, Renee, Maerz-Weiss, Pia, Catlett, Natalie L., Steiner, Guido, Wong, Ben, Wright, Matthew B., Blander, Gil, Elliston, Keith O., Ladd, William, Bobadilla, Maria, Mizrahi, Jacques, Haefliger, Carolina, Edgar, Alan |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
Public Library of Science
2012
|
Online Access: | http://hdl.handle.net/1721.1/71740 |
Similar Items
-
Pharmacological PPARβ/δ activation upregulates VLDLR in hepatocytes
by: Zarei, Mohammad, et al.
Published: (2020) -
Insights into the role of hepatocyte PPARα activity in response to fasting
by: Régnier, Marion, et al.
Published: (2020) -
Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity
by: Régnier, Marion, et al.
Published: (2020) -
Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models
by: Jain, Mukul R., et al.
Published: (2019) -
Virtual screening of pyrazole derivatives of usnic acid as new class of anti-hyperglycemic agents against PPARγ agonists
by: Roney, Miah, et al.
Published: (2023)